Cite
HARVARD Citation
Emens, L. et al. (n.d.). 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors. Journal for immunotherapy of cancer. p. A343. [Online].